Clinical trials

Efficacy and Safety of 3D185 Monotherapy in Subjects With Previously Treated Locally Advanced or Metastatic Cholangiocarcinoma

Study ID: NCT05039892

Sponsor

3D Medicines (Beijing) Co., Ltd.

A Study to Investigate Ubamatamab With and Without REGN7075 in Adult Participants With Advanced/Metastatic Non-Small Cell Lung Cancer (NSCLC)

Study ID: NCT07154290

Sponsor

Regeneron Pharmaceuticals

Hypofractionated, 3-week, Preoperative Proton or X-ray Radiotherapy for Patients With Localized Soft Tissue Sarcoma

Study ID: NCT07169344

Sponsor

Oslo University Hospital

Evaluate the Clinical Performance of the Flow Cytometry - FlowPath Lung Test as a Sensitive and Specific Non-invasive Diagnostic of Sputum Samples to Identify/Detect the Presence of Lung Cancer in High-risk Individuals Who Have Existing Lung Nodules, >6 to <30 mm in Diameter, Determined by LDCT.

Study ID: NCT07168993

Sponsor

bioAffinity Technologies Inc.

GVB-2001 Gene Therapy Via Intracameral Injection for the Treatment of Primary Open Angle Glaucoma

Study ID: NCT06921317

Sponsor

IVIEW Therapeutics Inc.

A Study in People With Idiopathic Pulmonary Fibrosis to Test Whether Pirfenidone Influences the Amount of BI 1015550 in the Blood

Study ID: NCT06241560

Sponsor

Boehringer Ingelheim

Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Study ID: NCT05962346

Sponsor

Mauro H. Schenone

Lactoferrin Use in ICU Patients

Study ID: NCT05936528

Sponsor

Mansoura University Hospital

Bone Marrow Aspirate Concentrate Versus Triamcinolone Injection For Hip Osteoarthritis

Study ID: NCT04990128

Sponsor

The Cleveland Clinic

Testing the Use of an IDH1 Inhibitor, Olutasidenib, in Acute Myeloid Leukemia Added to ASTX727 and Venetoclax; in High-Risk MDS Added to ASTX727; and Alone in Low Risk MDS (A MyeloMATCH Treatment Substudy)

Study ID: NCT07153497

Sponsor

National Cancer Institute (NCI)